The most recent trading session ended with Ginkgo Bioworks Holdings, Inc. (DNA) standing at $8.09, reflecting a -1.94% shift from the previouse trading day's closing. This change was narrower than the ...

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

This page features the latest news about the Ginkgo Bioworks stock. Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain ...

Kewalramani becme the first female CEO of a large, public U.S. biotechnology company after immigrating from India at age 11 ...

TIME magazine has released the list of the 100 Most Influential People of 2025 and Reshma Kewalramani, Indian-origin CEO, is ...

Founded in 2008, Ginkgo Bioworks is at the forefront of using biology to improve the world in multiple facets. DNA Articles 3 Stocks Hitting New 52-Week Lows.

Marie E. Fallon informed Ginkgo Bioworks (DNA) on May 1, 2023 of her intent to resign from her role as Chief Accounting Officer of... ByInvesting.com • May 05, 2023 Ginkgo Bioworks and Syngenta ...

Born in Mumbai, Reshma moved to the United States in 1988. She pursued a career in medicine, earning her degree from Boston ...

From US president Donald Trump to Tesla CEO Elon Musk, Time Magazine's 100 Most Influential People of 2025 list included some ...

Reshma is the kind of leader who can deliver that extraordinary future—it only seems crazy because no one’s done it before. I ...

Trained in internal medicine and nephrology, Reshma once intended to teach, treat patients, and work in a lab after medical ...